Roche is set to partner with Broad Clinical Labs for developing pilot applications leveraging its next-generation sequencing (NGS) Sequencing By Expansion (SBX) technology.

Roche 's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer ...

Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation sequencing. SBX chemistry, combined with an innovative ...

The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche's SBX sequencing technology 1, with an initial focus on critically ill newborns and their parents ...

"The science behind SBX technology represents a significant breakthrough that addresses the limitations of existing sequencing solutions,” states Matt Sause, CEO of Roche Diagnostics. "By integrating ...

About Sequencing by Expansion (SBX) technology Roche's groundbreaking next-generation sequencing technology is designed to overcome the limitations of traditional sequencing methods. As well as ...

Aktien » Nachrichten » ROCHE HOLDING AG GS » F. Hoffmann-La Roche Ltd: Roche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technology ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) unveiled today its proprietary, breakthrough sequencing by expansion (SBX) technology, establishing a new category of next-generation sequencing. SBX chemistry, ...

Stratos Genomics was acquired by Roche in 2020. To find out more about Roche’s novel SBX technology, click here. About Roche’s Sequencing Portfolio Roche has been committed to providing ...